The adverse cardiovascular risk factor profile of women with pre-eclampsia develops over time in the years before pregnancy

被引:11
作者
Retnakaran, Ravi [1 ,2 ,3 ]
Shah, Baiju R. [3 ,4 ,5 ,6 ]
机构
[1] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Toronto, ON, Canada
[2] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[3] Univ Toronto, Div Endocrinol, Toronto, ON, Canada
[4] Inst Clin & Evaluat Sci, Toronto, ON, Canada
[5] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON, Canada
[6] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
关键词
cardiovascular risk factors; glucose; lipids; preconception; pre-eclampsia; pregravid; DISEASE; COMPLICATIONS; PREVENTION; DISORDERS; STATE;
D O I
10.1111/1471-0528.17084
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective Women with a history of pre-eclampsia have an elevated lifetime risk of cardiovascular disease that may be partly attributed to an adverse cardiovascular risk factor profile, the etiology of which is unclear. Hypothesising that this adverse risk profile may begin to arise over time in the years before pregnancy, we sought to evaluate the pregravid changes over time in cardiovascular risk factors in women who go on to develop pre-eclampsia and those who do not. Design Retrospective cohort study using population-based administrative databases. Setting Ontario, Canada. Population All nulliparous women who had singleton pregnancies between January 2011 and December 2018. Methods All results for the following analytes between January 2008 and the start of pregnancy were identified: A1c, glucose, lipids, and transaminases. Mean values were compared between those with and without preeclampsia. The annual change for each analyte in the years before pregnancy was estimated using generalized estimating equations. Main outcome measure Preeclampsia. Results The 156 278 women (of whom 3827 developed preeclampsia) had mean 4.0 +/- 3.3 pregravid tests overall. The two most recent pregravid tests were performed at median 0.6 and 1.9 years before pregnancy, respectively. Women who developed pre-eclampsia had higher pregravid A1c, fasting glucose, random glucose, LDL-cholesterol, triglycerides, and ALT, and lower HDL-cholesterol, than their peers (all P < 0.0001). In the years before pregnancy, women who went on to develop pre-eclampsia had higher annual increases than their peers in triglycerides (13.8-fold higher; P = 0.0004) and random glucose (1.55-fold higher; P = 0.001), coupled with a greater annual decrease in HDL-cholesterol (9.7-fold higher; P = 0.002). During this time, fasting glucose increased in women who developed pre-eclampsia but decreased in their peers (P = 0.01). Conclusion In women who develop pre-eclampsia, an adverse cardiovascular risk factor profile evolves over time in the years before pregnancy.
引用
收藏
页码:1512 / 1520
页数:9
相关论文
共 23 条
[1]   Metabolic syndrome in the non-pregnant state is associated with the development of preeclampsia [J].
Cho, Geum Joon ;
Park, Jong Heon ;
Shin, Soon-Ae ;
Oh, Min-Jeong ;
Seo, Hong Seog .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 203 :982-986
[2]   Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women JACC State-of-the-Art Review [J].
Cho, Leslie ;
Davis, Melinda ;
Elgendy, Islam ;
Epps, Kelly ;
Lindley, Kathryn J. ;
Mehta, Puja K. ;
Michos, Erin D. ;
Minissian, Margo ;
Pepine, Carl ;
Vaccarino, Viola ;
Volgman, Annabelle Santos .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (20) :2602-2618
[3]   Associations of Pregnancy Complications With Calculated Cardiovascular Disease Risk and Cardiovascular Risk Factors in Middle Age The Avon Longitudinal Study of Parents and Children [J].
Fraser, Abigail ;
Nelson, Scott M. ;
Macdonald-Wallis, Corrie ;
Cherry, Lynne ;
Butler, Elaine ;
Sattar, Naveed ;
Lawlor, Debbie A. .
CIRCULATION, 2012, 125 (11) :1367-1380
[4]  
Grandi SM, 2019, CIRCULATION, V139, P1069, DOI [10.1161/CIRCULATIONAHA.118.036748, 10.1161/circulationaha.118.036748]
[5]   Prepregnancy vascular dysfunction in women who subsequently develop hypertension during pregnancy [J].
Hale, Sarah A. ;
Badger, Gary J. ;
McBride, Carole ;
Magness, Ronald ;
Bernstein, Ira M. .
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH, 2013, 3 (02) :140-145
[6]   Preconception Cardiovascular Risk Factors and Pregnancy Outcome [J].
Harville, Emily W. ;
Viikari, Jorma S. A. ;
Raitakari, Olli T. .
EPIDEMIOLOGY, 2011, 22 (05) :724-730
[7]   Life Course Trajectories of Cardiovascular Risk Factors in Women With and Without Hypertensive Disorders in First Pregnancy: The HUNT Study in Norway [J].
Haug, Eirin B. ;
Horn, Julie ;
Markovitz, Amanda R. ;
Fraser, Abigail ;
Vatten, Lars J. ;
Macdonald-Wallis, Corrie ;
Tilling, Kate ;
Romundstad, Pal R. ;
Rich-Edwards, Janet W. ;
Asvold, Bjorn O. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (15)
[8]   Adverse pregnancy outcomes and future maternal cardiovascular disease [J].
Hauspurg, Alisse ;
Ying, Wendy ;
Hubel, Carl A. ;
Michos, Erin D. ;
Ouyang, Pamela .
CLINICAL CARDIOLOGY, 2018, 41 (02) :239-246
[9]   Biochemical Cardiovascular Risk Factors After Hypertensive Pregnancy Disorders: A Systematic Review and Meta-analysis [J].
Hermes, Wietske ;
Ket, Johannes C. F. ;
van Pampus, Maria G. ;
Franx, Arie ;
Veenendaal, Marjolein V. E. ;
Kolster, Clara ;
Tamsma, Jouke T. ;
Bloemenkamp, Kitty W. M. ;
Ponjee, Gabrielle ;
van der Hout, Evelien ;
ten Horn, Hilde ;
Loix, Stephanie ;
Mol, Ben Willem ;
de Groot, Christianne J. M. .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2012, 67 (12) :793-809
[10]   Postpartum Care in the United States - New Policies for a New Paradigm [J].
Horwitz, Mara E. Murray ;
Molina, Rose L. ;
Snowden, Jonathan M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1691-1693